Please login to the form below

Not currently logged in
Email:
Password:

Electronic medical records industry to soar

Report says market will hit $17bn by 2017

The electronic medical records (EMR) market value is expected to from $10.6bn to hit $17bn by 2017, according to new research.

The paper, compiled by consulting firm GlobalData, said this rapid growth in value is led by the US, which introduced an act in 2009 requiring all healthcare providers to create an electronic system for their patients' medical records by 2014.

The fruits of the American Relief and Recovery Act of 2009 are now beginning to bear, helping the huge but fragmented healthcare market of the US catch up to the likes of South Korea and Turkey, which have national electronic medical records managed via a central office.

GlobalData analyst Adam Dion commented on the impact of the American Relief and Recovery Act of 2009.

He said: “Physicians are selecting and implementing EMRs that meet federal requirements for meaningful use, and which also fit their practices and provide opportunities to enhance productivity, capture profits, and improve clinical outcomes.”

EMR vendors are also offering revenue cycle management (RCM) solutions to healthcare practices to bridge the gap between clinical and financial information, said GlobalData. These include GE Healthcare's Centricity Business, which unites clinical and administrative staff on the same financial platform.

Of the companies benefiting from the rising importance of EMRs, McKesson had the largest healthcare IT software and services revenue in 2012, with turnover of $3.3bn, making it the EMR market leader. The next highest revenues were generated by Cerner and Allscripts, with $2.7bn and $1.5bn, respectively.

The rise of EMRs will  be of interest for pharma companies looking to tap the data for clinical research.

Speaking to PMLiVE last year, Dr Lollo Eriksson of contract research organisation Paraxel commented that this data can help identify trial participants more quickly and efficiently, reducing costs and trial times.


Article by
Tara Craig

11th February 2014

From: Research, Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics